Icon has reached a preliminary agreement with Intel to use the Intel Pharma Analytics Platform in clinical trials. Launched in 2013, the Intel platform can continuously monitor and collect clinical ...
Gelsinger's comments offended TSMC, which did not honor discount Revenue and stock price have declined sharply under Gelsinger Intel's 18A chip process faces delays and technical issues Oct 29 ...
YouTube on MSN
Intel Core i9-9900KS review - we hit 5.2GHz on all cores
We've been hearing about it for a while, but today the review embargo has lifted on Intel's Core i9-9900KS. What does Luke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback